Morphogen-related therapeutic targets for liver fibrosis.
about
Loss of pericyte smoothened activity in mice with genetic deficiency of leptin.The gene expression profile of a drug metabolism system and signal transduction pathways in the liver of mice treated with tert-butylhydroquinone or 3-(3'-tert-butyl-4'-hydroxyphenyl)propylthiosulfonate of sodiumHedgehog regulates yes-associated protein 1 in regenerating mouse liver.
P2860
Morphogen-related therapeutic targets for liver fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Morphogen-related therapeutic targets for liver fibrosis.
@en
type
label
Morphogen-related therapeutic targets for liver fibrosis.
@en
prefLabel
Morphogen-related therapeutic targets for liver fibrosis.
@en
P2860
P1476
Morphogen-related therapeutic targets for liver fibrosis.
@en
P2093
Eileen Fung
Hidekazu Tsukamoto
P2860
P304
P356
10.1016/J.CLINRE.2015.05.017
P478
39 Suppl 1
P577
2015-07-20T00:00:00Z